These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 7921715

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Psychopathology of panic attacks in panic disorder.
    Uhlenhuth EH, Leon AC, Matuzas W.
    J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
    [Abstract] [Full Text] [Related]

  • 23. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF.
    Behav Res Ther; 1996 May; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract] [Full Text] [Related]

  • 24. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterological traits of recovered patients with panic disorder and agoraphobia.
    Saviotti FM, Grandi S, Savron G, Ermentini R, Bartolucci G, Conti S, Fava GA.
    J Affect Disord; 1991 Nov; 23(3):113-7. PubMed ID: 1774426
    [Abstract] [Full Text] [Related]

  • 27. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ.
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [Abstract] [Full Text] [Related]

  • 28. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J, Houbová P, Novák T, Záleský R, Espa-Cervená K, Pasková B, Vyskocilová J.
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [Abstract] [Full Text] [Related]

  • 29. Belief disconfirmation versus habituation approaches to situational exposure in panic disorder with agoraphobia: a pilot study.
    Salkovskis PM, Hackmann A, Wells A, Gelder MG, Clark DM.
    Behav Res Ther; 2007 May; 45(5):877-85. PubMed ID: 17296165
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term outcome of panic disorder with agoraphobia treated by exposure.
    Fava GA, Rafanelli C, Grandi S, Conti S, Ruini C, Mangelli L, Belluardo P.
    Psychol Med; 2001 Jul; 31(5):891-8. PubMed ID: 11459386
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Behavioral aspects of panic disorder.
    Marks IM.
    Am J Psychiatry; 1987 Sep; 144(9):1160-5. PubMed ID: 2888322
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A, Coutu MF, Dupuis G, Fleet R, Borgeat F, Todorov C, Mainguy N.
    Cogn Behav Ther; 2008 Sep; 37(3):146-59. PubMed ID: 18608313
    [Abstract] [Full Text] [Related]

  • 38. Two cases of panic disorder treated with autogenic training and in vivo exposure without medication.
    Sakai M, Takeichi M.
    Psychiatry Clin Neurosci; 1996 Dec; 50(6):335-6. PubMed ID: 9014233
    [Abstract] [Full Text] [Related]

  • 39. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B, Broocks A, Pekrun G, George A, Meyer T, Pralle L, Bartmann U, Hillmer-Vogel U, Rüther E.
    Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.